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ABSTRACT
Background:  The sensitivity of radiographic 
examination in the diagnosis and severity assessment 
of knee osteoarthritis (OA) is still low. Various 
attempts have been made to find more reliable 
indicators of cartilage damage. One potential marker 
is cartilage oligomeric matrix protein (COMP), a 
substance that in previous animal studies had been 
shown to be released in proportion to the extent of 
joint cartilage damage.
Objective:  To evaluate the correlation between the 
severity of knee OA and serum level of COMP in human 
with normal renal function.
Methods:  This was a cross-sectional study 
performed at the outpatient clinic in Department of 
Internal Medicine, Sanglah Hospital, Denpasar. The 
diagnosis of knee OA was based on the American 
College of Rheumatology (ACR) criteria. The degree 
of knee OA severity was determined by using the 
Kellgren-Lawrence criteria, while COMP values were 
checked by enzyme-linked immunosorbent assay 
(ELISA) method.
Results:  Forty five patients who were recruited were 
examined: 19 (42.2%) were female and 26 (57.8%) 
were male. The mean age of patients was 64.1±7.1 
years. There were 4.4%, 26.7%, 46.7%, and 22.2% 
patients who had grade 1st, 2nd, 3rd, and 4th degree 
joint damage based on the Kellgren-Lawrence score, 
respectively. Mean serum level of COMP was
1081.4 ng/mL. We found a significant correlation of 
the severity of knee OA with serum level of COMP
(r = 0.41, p = 0.005).
Conclusion:  Among the patients in this study, there 
was a significant correlation between the severity of 
joint damage in knee OA and serum level of COMP.
Osteoarthritis (OA) is the most common articular 
disease in humans.1 World Health Organization 
(WHO) estimated 25% of people aged 65 years 
old around the world suffer from this disease.2 
Radiographic studies conducted in America and 
Europe reported the prevalence of knee OA in 
people aged 45 years or more is 14% in men and 
22.8% in women.3
In Indonesia the prevalence of knee OA 
through radiologic fi ndings reaches 15.5% in 
men and 12.7% in women.4 Several studies 
conducted in Indonesia even shows a higher result 
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compared to America. A study done at the Internal 
Medicine outpatient clinic in Manado General 
Hospital (March 1994-November 1995) showed a 
prevalence of 36.81% and 37.55% in Surabaya.5 
Surveys conducted at the Rhemathology outpatient 
clinic of Sanglah Denpasar Hospital (2001 – 2002) 
demonstrated OA as the most frequent rheumatic 
cases (37%) where the majority of them were knee 
OA (97%).6 
Osteoarthritis can affect many joints, more often 
the weight bearing joints such as hips and knees.3 
The prevalence of OA is expected to increase along 
with the increase of obesity as its major risk factor 
and a higher life expectancy. Pain, infl ammation, 
and joint stiffness due to osteoarthritis may cause 
physical disability. In the United states, OA not only 
became the major cause of physical disability but 
also the expense incurred for this disease in 2001 
reached 81 million dollars and an indirect cost of 
approximately 47 million dollars.7 In Indonesia it 
is expected that 1-2 million elderly suffer handicap 
due to OA.4
To prevent the increasing number of handicap, 
an early diagnosis and accurate assessment of OA 
severity is needed. The current assessment is neither 
uniform nor objective due to its high dependency to 
the skill and experience of radiologists. By the time 
of diagnosis, OA has usually in an advance stage 
because conventional radiographs have limited 
capacity in detecting early stages of OA. This 
condition implies a higher failure in preventing 
physical disability. Therefore a marker that can 
detect cartilage damage as an objective assessment 
of OA is necessary, especially if it can predict early 
stages of this disease. 
During the cartilage matrix turn over, both 
in normal and pathologic states, metabolites 
and fragments of the cartilage matrix will be 
released to blood and synovial fl uid. One of these 
macromolecules is cartilage oligomeric matrix 
protein (COMP). The structure of this cartilage-
specifi c protein is similar to trombospondin. COMP 
is known to stabilize articular cartilage matrix 
by binding to collagen and other extracellular 
components.7,8,9 According to a study by Geng et al. 
(2008), Wistar rats deprived of COMP undergoes 
immediate arthritis reaction and later developing 
into severe chronic arthritis. Another study 
conducted in experimental animals that were made 
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OA, COMP was found to be expressed at the earliest phase 
of cartilage damage10 and its level increases along with the 
grading of OA. 11
The aim of this study is to evaluate the correlation between 
knee OA severity with serum levels of COMP in humans. 
METHODS
Study Design
This was a cross sectional study. Samples were taken from 
the Internal Medicine Outpatient Clinic at Sanglah Hospital, 
Denpasar during 2010-2011. 
Samples recruitment
Sample inclusion criteria were patients who fulfi lled the 
American Clinical Rheumatology (ACR) 1996 criteria for 
knee OA, aged more than 50 years old, and have agreed to 
participate by signing informed consent. Samples excluded 
in this study were patients with total articular space damage 
(no space left) from radiologic examinations, OA in joints 
other than knee, articular diseases other than OA, patients that 
were unable to stand without assistance, using or having used 
steroids for the last 2 weeks, and creatinine clearance below 
60 ml/minute. 
Assessment
Knee OA severity was assessed according to the Kellgren 
Lawrence grading scale. Knee OA is classifi ed into 5 grades 
(fi gure 1): grade 0 with normal radiologic fi ndings; grade 
1 with doubtful narrowing of joint spaces and possible 
osteophytic lipping; grade 2 with defi nite osteophytes and 
defi nite narrowing of joints space; grade 3 with moderate 
multiple osteophytes, defi nite narrowing of joints space, 
some sclerosis and possible deformity of bone contour; and 
grade 4 with large osteophytes, marked narrowing of joints 
space, severe sclerosis and defi nite deformity of bone contour. 
Radiographic examination of patients was done in a standing 
position, where anteroposterior (AP) and lateral projection of 
both knees were taken. Radiographs were then examined by 
three qualifi ed radiologists that had been tested with a reability 
test (kappa test). 
Figure 1. Kellgren Lawrence grading scale of knee OA
Sera for COMP were collected 3 hours after the patient 
woke up in the morning and rested approximately 30 minutes. 
To determine serum COMP levels, samples were examined 
with Human Cartilago Oligomeric Matrix Protein ELISA 
(Biovendor, Brno, Czech Republic) reagent. The examination 
using Biovendor reagent had a limit of detection (LOD) of 0,4 
ng/mL.
Statistical Analysis 
Data normality of COMP levels were assessed using the 
Shapiro-Wilk test. Correlation between serum COMP levels, 
knee OA gradings, and age were analyzed with the Spearman 
and Pearson test according to the normality data. Relations 
of gender and serum COMP levels were assessed by T-test. 
Statistical signifi cance used was p <0,05. Linear regression 
multivariate tests were used to estimate serum COMP levels 
prediction using knee OA severity.
RESULTS 
Forty fi ve patients enrolled in this study, of which 19 (42,4%) 
patients were male and 26 (57,8%) patients were female. 
Serum levels and knee x-ray were examined. Average age 
of sample was 63.3±6.8 years with a range between 50 to 
85 years old. Most frequent education background was high 
school (60%) and most frequent occupation was civil servant 
or retired civil servants. 
Most frequent OA grading based on Kellgren-Lawrence 
grading scale was grade 3. Mean serum COMP level was 
1175,4 ng/ml. Mean body mass index (BMI) was 26,2 kg/
m2 also included as grade 1 obesity based on Western Pacifi c 
Region of WHO 2000 classifi cation. Sample characteristics 
are shown in table 1. 
Tabel 1   Characteristics of based sample (N = 45)
Characteristics n (%)*
Gender
male
female
Age, years, mean (SD)
Education backround
No education
elementary
junior high school
high school
University
Work
unemployed
labor
farmer
civil servants (PNS)
private sector
Military-police
BMI, kg/m2, mean (SD)
COMP level, ng/mL, mean (SD)
COMP level, ng/mL, median (range)**
   Grade 0
Grade 1
Grade 2
Grade 3
Grade 4
Degree of Joint damage
   Grade 0
Grade 1
Grade 2
Grade 3
   Grade 4
19 (42,2)
26 (57,8)
63,3 (6,8)
1 (2,2)
6 (13,3)
2 (4,4)
27 (60,0)
9 (20,2)
8 (17,8)
0 (0)
0 (0)
30 (66,7)
4 (8,9)
3 (6,7)
26,2 (4,2)
1081,4 (3,3)
0 (0)
868,4 (613,5–1123,3)
881,3 (683–1197,5)
11124,3 (673,6–2177,8)
1273,9 (816,9–2278,6)
0 (0)
2 (4,4)
12 (26,7)
21 (46,7)
10 22,2)
 
* unless otherwise noted
** data distribution is not normal therefore described in median and range
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Reability of knee radiographs in determining severity of knee OA
Three radiologists were tested with a kappa test (k) before 
assessing knee radiographs to determine OA grade based on 
Kellgren-Lawrence criteria. Assays were based on the readings 
of 20 samples of knee radiographs by two radiologists. The 
kappa value attained was 0,595. This was included an adequate 
criteria. 12 
Correlation between severity of knee OA and serum COMP 
levels
Positive correlations were found statistically signifi cant, using 
the Spearman correlation test, with r = 0,41 and p = 0,005. 
Therefore there was a tendency of increasing grade of knee 
OA along with increase COMP serum levels (fi gure 2).
Figure 2   Relationship between knee OA severity grade (K/L) 
with COMP serum 
Correlation of Age and COMP serum level 
Two methods were used to test the relationship between age 
and COMP serum levels. The fi rst test was done by correlation 
test. The second test was done by test comparing COMP serum 
levels after they were categorized into 2 age groups of < 65 
years and ≥ 65 years old. In the correlation test a tendency of 
increase COMP serum levels with age was found, but with no 
signifi cant correlation (r = 0,103; p = 0,5) (Figure 4).
Figure 4   Relationship between age and COMP serum
The compare test of COMP serum in the age groups < 65 
years old and ≥ 65 years displayed no signifi cant difference (t 
= -8,53; p = 0,398). 
Correlation of gender and COMP serum level
In this study, no signifi cant difference was found of log10-
COMP serum between male and female (t = 0,802, p = 0,427). 
However, the results show a higher COMP serum levels in 
male than female (Table 2)
Table 2   COMP serum levels based on gender
Sex Mean COMP serum (ng/mL) p
Male 1.135,6 (391,4) 0.427
Female 1.041,7 (318,8)
Multivariate Analysis
Linear regression was used as the multivariate analysis to 
look at factors infl uencing COMP serum. From the analysis 
results, only knee OA severity grade (p <0,25) were eligible 
to be included in the multivariate analysis. Other variables 
such as gender and age could not be included because their 
p values were > 0,25. Based on the linear regression analysis, 
equation of COMP was obtained, COMP = 573 + 177,3 (knee 
OA severity grade). The above equation is feasible because 
ANOVA test display p = 0,005. However, knee OA severity 
grading can only explain COMP serum concentration of 
15,1% based on adjusted R square linear regression test dan 
Anova value. 
DISCUSSION
In a study done by Clark et al11 COMP serum obtained from 
the control group was 1.061,83±370.83 ng/mL , whereas OA 
patient group was 1.208,57±487,47 ng/mL. Another study 
was done by Jordan et al13 examining COMP serum levels 
corresponding the knee OA severity grade (K/L). After 
transforming the data using natural logarithm, the mean 
COMP serum levels in knee OA (±SD) is as follow; grade 0 of 
6.68±0.40, grade 2 of 6.79±0.40, grade 3 of 6.87±0.34, grade 
4 of 7.00±0.48. In this study, the distribution value of COMP 
levels was not normal with a mean COMP level in knee OA 
patients of 1.081,4 ng/mL ranging between 613,5 to 2.278,6 
ng/mL. This data was lower when compared with the previous 
two studies.
Previous studies investigating the relationship between 
arthritis and serum COMP levels have been conducted in both 
experimental animals and humans. Experimental animals that 
were made to have arthritis demonstrated an increased level 
of COMP in late phase after further cartilage damage, but not 
at the beginning when infl ammation peaked.14,15 This study 
showed that increased COMP in blood was due to articular 
cartilage damage. In another study, elevated levels of COMP 
were found higher in experimental animals that had severe 
arthritis damage compared with mild damage. 14,15 This study 
implied severe degree of arthritis meant more COMP. 
Research studying the relationship between OA and COMP 
serum levels in humans by Petersson et al16 exhibited samples 
with no OA in previous radiologic examinations then later on 
had OA. They showed a higher concentration of COMP serum 
compared with those without OA after being follow up for 
three years. 
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A tendency of increasing knee OA severity grade along 
with COMP serum levels was found in this study and showed 
a correlation that was statistically signifi cant. In Indonesia, 
research on the correlation between knee OA severity grade 
with COMP serum has never been conducted. The research 
done by Conrozier et al17 was on the correlation between hip 
OA severity grade with COMP serum. In the study a signifi cant 
correlation was found between COMP and joint space width 
(JSW) (r = 0,40; p = 0,001). COMP value was also connected 
to yearly mean narrowing (YMN) of the hips (r = 0,38; p = 
0,002).
Researches related to knee OA had been done before, 
comparing the average levels of COMP serum in patients with 
different OA grading. One the researches was conducted by 
Clarck et al (1990) who compared COMP serum levels in OA 
patients and control group. As a result, patients with grade 3 
and 4 knee OA had an average COMP serum of 21,3% higher 
(p = 0,013) compared with the control group and patients with 
grade 2 knee OA had an average COMP serum 11,5% higher 
than the control group (p = 0,045). Although average COMP 
serum levels tended to be higher in grade 3 - 4 knee OA than 
to grade 2 but this did not differ signifi cantly. 11 
In this research, the average COMP serum levels were 
compared between groups of severe knee OA group (grade 
3 and 4) with mild knee OA (grade 1 and 2) and obtained 
a signifi cant difference (t = -3,04; p = 0,004). This data 
supported previous theory stating that higher grade OA had 
higher COMP serum level.
However, the use of serum COMP as a tool to assess the 
severity of knee OA, based on these results, can not be fully 
utilized because the levels of serum COMP vary in each 
grade of OA (a sample of grade 4 knee OA was found having 
a COMP level below the average COMP level of grade 2) 
(Figure 3). 
Multivariate analysis (linear regression) showed that, 
although the equation on the infl uence of knee OA severity 
grading with COMP serum could be used, it could only 
explain as much as 15,1% COMP serum levels. Possibly, there 
are other factors infl uencing COMP levels that has not been 
investigated. Another cause may be the reability (or kappa) 
of determining knee OA from radiographs is not included as 
good criteria. In this study, the kappa value of radiographic 
readings in determining knee OA grade based on Kellgren 
Lawrence criteria was moderate. For further research, kappa 
values should be increased by training. Another alternative 
is by using better modalities such as MRI in assessing the 
severity of OA.
Besides the grading of knee OA severity, several other 
factors may affect serum COMP levels, such as age, sex, and 
impaired excretion due to kidney disease. Effect of impaired 
renal function can be ignored because patients with these 
conditions are excluded fi rst.
There were a few of limitations in this study. One of the 
criteria used for inclusion OA samples was clinical in which 
the diagnosis of OA can only be made if there was a complaint. 
OA patients without clinical complaints are unlikely to be 
included as a study sample therefore affecting the COMP 
serum levels obtained. Moreover, assessment of OA grade 
with knee radiographs using Kellgren-Lawrence criteria only 
achieve a reliability (kappa value= 0.6) of moderate. 
CONCLUSION
This study concluded that there was a signifi cant correlation 
between knee OA severity grades with COMP serum levels. 
Strength criteria included moderate correlation (r= 0.41). 
However, using serum COMP level to assess the severity of 
knee OA is not applicable because of varying level of serum 
COMP in each grade of OA. Further efforts to a better and 
objective assessment of OA severity can be made by increasing 
the value of kappa or using better modalities should another 
research is planned to cover the limitations in this research.
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